Risk Of Breast Cancer Recurrence May Depend On Treating Surgeon

Ductal carcinoma in situ (DCIS), or non-invasive breast cancer, is typically treated with either breast-conserving surgery – with or without follow-up radiation – or mastectomy. The treatment choice depends on clinical factors, the treating surgeon, and patient preferences. Long-term health outcomes (disease-free survival) depend on the treatments received…

Direct Link Between Drop In Breast Cancer Rates And Reduced Hormone Therapy

In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer…

Jane Fonda Confirms Non-Invasive Breast Cancer Scare

Jane Fonda, the 72-year old Oscar-winning actress turned fitness guru has confirmed she had a scare with non-invasive breast cancer; she has had a small tumor removed and says she is now cancer free…

Breast Cancer Risk In Postmenopausal Osteoporotic Women Reduced By Lasofoxifene

Lasofoxifene statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density, according to a study published online in The Journal of the National Cancer Institute. Lasofoxifene is a SERM, or selective estrogen receptor modulator, that, like tamoxifen, blocks the effects of estrogen in breast tissue…

Hormone Therapy Increases Breast Cancer And Mortality

Results of a new Women’s Health Initiative (WHI) report show that hormone therapy is associated with an increased the risk of death from breast cancer, as well as an increased risk of developing invasive breast cancer in postmenopausal women…

Next Page »